FindTrial
Sign In

Clinical, molecular characteristics and telomere maintaining mechanism of spinal cord glioma with or without H3 K27M mutation

Clinical, molecular characteristics and telomere maintaining mechanism of spinal cord glioma with or without H3 K27M mutation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106056
Enrollment
Unknown
Registered
2025-07-16
Start date
2025-05-26
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal glioma with H3 K27M mutant

Interventions

The H3 K27-altered group:None
H3 K27 wild-type group:None

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with spinal cord glioma in our hospital from January 2016 to January 2025 were enrolled, regardless of age and gender.

Exclusion criteria

Exclusion criteria: Patients with other spinal cord tumors

Design outcomes

Primary

MeasureTime frame
Pathological result;—

Secondary

MeasureTime frame
Survival time;Tumor size;Age;Gender;Whether to carry out adjuvant therapy;Surgical method;Tumor location;—

Countries

China

Contacts

Public ContactJun Tan

Xiangya Hospital Central South University

tanjunsea@csu.edu.cn+86 15874231665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026